CAS 2245255-66-5
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte.
(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt
CAS:Formel:C21H33F3N8O7Reinheit:98%Farbe und Form:SolidMolekulargewicht:566.5313GSK2807 Trifluoroacetate
CAS:GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).Formel:C21H33F3N8O7Reinheit:99.95%Farbe und Form:SolidMolekulargewicht:566.53(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt
CAS:Reinheit:98%Molekulargewicht:566.5390015GSK2807 Trifluoroacetate
CAS:<p>GSK2807 Trifluoroacetate is a selective inhibitor, specifically targeting the lysine acetyltransferase MYST3 (MOZ), which is derived synthetically through medicinal chemistry. This compound functions by competitively inhibiting the acetylation of histone lysine residues, crucial components in the regulation of gene expression through chromatin modification. The inhibition of MYST3 disrupts its role in facilitating transcriptional activation by modulating chromatin structure, thereby impairing the recruitment of transcription factors and other co-regulatory proteins essential for gene expression.</p>Formel:C21H33F3N8O7Reinheit:Min. 95%Molekulargewicht:566.53 g/mol
